4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0000947871-26-000458
Director sold 55,345 shares at an average $44.67 ($2,472,343)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ORBIMED ADVISORS LLC · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-17 | Sale : show line 1 in the form 10b5-1 | −52,397 | $44.68 | $2,341,098 | 2,967,722 | I |
| 2026-04-18 | Sale : show line 2 in the form 10b5-1 | −2,948 | $44.52 | $131,245 | 2,964,774 | I |
| Open-market sales · 55,345 sh · avg $44.67 · $2,472,343 | ||||||
Loading xslF345X06/ownership.xml…